Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Swartz

We'll know for certain if Swartz files a Schedule 13G, which has been done sometime in February for the last two years.  If he doesn't file one, I think that means he owns less than 5% of outstanding shares.

Unfortunately, we wait.

Share
New Message
Please login to post a reply